Removing certain drugs from schedule one
House Bill 2854 would amend West Virginia’s Uniform Controlled Substances Act by revising the state’s Schedule I list of controlled substances. The bill’s stated purpose is to remove certain substances from Schedule I, specifically including marihuana, psilocybin, and tetrahydrocannabinols, while leaving in place a very large list of other Schedule I substances and related chemical classes. The text is largely a detailed schedule update, listing numerous opioids, hallucinogens, synthetic cannabinoids, depressants, stimulants, cathinones, fentanyl analogs, and other compounds that would remain controlled.
The bill also preserves an exception for tetrahydrocannabinols that are lawfully manufactured, distributed, or possessed under existing West Virginia hemp/cannabis laws, indicating an effort to align the controlled-substances schedule with other state regulatory frameworks. In practical terms, the measure would narrow the scope of Schedule I by removing the named substances from that category, which could affect criminal enforcement, prosecution, and regulatory treatment of those substances under state law.
If enacted, HB2854 would amend §60A-2-204 of the West Virginia Code, changing the contents of Schedule I under the Uniform Controlled Substances Act. The principal legal effect would be to remove marihuana, psilocybin, and tetrahydrocannabinols from Schedule I, while keeping the rest of the schedule intact and continuing to regulate many synthetic and analog substances. This would affect law enforcement, courts, prosecutors, and regulated parties by changing which substances are treated as Schedule I controlled substances under state law.
The available record shows the bill was introduced by Delegates Young, Pushkin, and Lewis and referred to the House Committee on Health and Human Resources and then the Judiciary, but there are no committee transcripts or recorded votes provided. Based on the bill text alone, the measure appears to reflect a reform-oriented approach to controlled-substance scheduling, especially regarding cannabis and psilocybin. Because no discussion or voting history is available, there is no documented legislative sentiment in the provided materials beyond the bill’s stated intent.
The main point of contention is likely the proposal to remove marihuana, psilocybin, and tetrahydrocannabinols from Schedule I, since those substances are commonly associated with debates over drug policy, criminal penalties, medical use, and legalization. Supporters would likely view the change as modernizing the schedule and reducing penalties for substances increasingly discussed in medical or regulated-use contexts, while opponents may argue it weakens drug-control enforcement or conflicts with public-safety concerns. The bill text itself does not show any recorded objections, amendments, or committee debate, so these tensions are inferred from the subject matter rather than documented in the provided history.